Janine Porter-Steele
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Janine Porter-Steele has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra L. McCarthy
School of Nursing, Midwifery and Social Work, The University of Queensland, Level 3, Chamberlain Building (35), St Lucia, Queensland, 4072, Australia; Mater Research Institute, Level 3, Aubigny Place, Raymond Terrace, South Brisbane, Queensland 4101, Australia
2 shared publications - Debra Anderson
Faculty of Health University of Technology Sydney Sydney New South Wales Australia
2 shared publications - Alan Gordon Fraser
Department of Medicine, University of Auckland, Auckland, New Zealand
1 shared publication - Amanda McGuire
Menzies Health Institute Queensland and School of Nursing and Midwifery, Griffith University, Queensland, Australia
1 shared publication - Bobbi Laing
School of Nursing, Faculty of Medical & Health Sciences, University of Auckland, Auckland 1023, New Zealand
1 shared publication - Charrlotte Seib
School of Nursing and Midwifery – Nursing, Griffith University Logan Australia
1 shared publication
Latest Publications
- Open Access
- 8 July 2022
- Published by Springer Nature in BMC Cancer
- Vol. 22 (1) , 1-12
Improving health-related quality of life in women with breast, blood, and gynaecological Cancer with an eHealth-enabled 12-week lifestyle intervention: the women’s wellness after Cancer program randomised controlled trial
Background: The residual effects of cancer and its treatment can profoundly affect women’s quality of life. This paper presents results from a multisite randomized controlled trial that evaluated the clinical benefits of an e-health enabled health promotion intervention (the Women’s Wellness after Cancer Program or WWACP) on the health-related quality of life of women recovering from cancer treatment. Methods: Overall, 351 women previously treated for breast, blood or gynaecological cancers were randomly allocated to the intervention (WWACP) or usual care arms. The WWACP comprised a structured 12-week program that included online coaching and an interactive iBook that targeted physical activity, healthy diet, stress and menopause management, sexual wellbeing, smoking cessation, alcohol intake and sleep hygiene. Data were collected via a self-completed electronic survey at baseline (t0), 12 weeks (post-intervention, t1) and 24 weeks (to assess sustained behaviour change, t2). The primary outcome, health-related quality of life (HRQoL), was measured using the Short Form Health Survey (SF-36). Results: Following the 12-week lifestyle program, intervention group participants reported statistically significant improvements in general health, bodily pain, vitality, and global physical and mental health scores. Improvements were also noted in the control group across several HRQoL domains, though the magnitude of change was less. Conclusions: The WWACP was associated with improved HRQoL in women previously treated for blood, breast, and gynaecological cancers. Given how the synergy of different lifestyle factors influence health behaviour, interventions accounting for the reciprocity of multiple health behaviours like the WWACP, have real potential for immediate and sustainable change. Trial registration: The protocol for this randomised controlled trial was submitted to the Australian and New Zealand Clinical Trials Registry on 15/07/2014 and approved on 28/07/2014 (ACTRN12614000800628).
- 8 July 2022
- Published by Springer Nature in BMC Cancer
- Vol. 22 (1) , 1-12
Open AccessImproving health-related quality of life in women with breast, blood, and gynaecological Cancer with an eHealth-enabled 12-week lifestyle intervention: the women’s wellness after Cancer program randomised controlled trial
Background: The residual effects of cancer and its treatment can profoundly affect women’s quality of life. This paper presents results from a multisite randomized controlled trial that evaluated the clinical benefits of an e-health enabled health promotion intervention (the Women’s Wellness after Cancer Program or WWACP) on the health-related quality of life of women recovering from cancer treatment. Methods: Overall, 351 women previously treated for breast, blood or gynaecological cancers were randomly allocated to the intervention (WWACP) or usual care arms. The WWACP comprised a structured 12-week program that included online coaching and an interactive iBook that targeted physical activity, healthy diet, stress and menopause management, sexual wellbeing, smoking cessation, alcohol intake and sleep hygiene. Data were collected via a self-completed electronic survey at baseline (t0), 12 weeks (post-intervention, t1) and 24 weeks (to assess sustained behaviour change, t2). The primary outcome, health-related quality of life (HRQoL), was measured using the Short Form Health Survey (SF-36). Results: Following the 12-week lifestyle program, intervention group participants reported statistically significant improvements in general health, bodily pain, vitality, and global physical and mental health scores. Improvements were also noted in the control group across several HRQoL domains, though the magnitude of change was less. Conclusions: The WWACP was associated with improved HRQoL in women previously treated for blood, breast, and gynaecological cancers. Given how the synergy of different lifestyle factors influence health behaviour, interventions accounting for the reciprocity of multiple health behaviours like the WWACP, have real potential for immediate and sustainable change. Trial registration: The protocol for this randomised controlled trial was submitted to the Australian and New Zealand Clinical Trials Registry on 15/07/2014 and approved on 28/07/2014 (ACTRN12614000800628).
- Open Access
- 29 April 2022
- Published by MDPI AG in Medical Sciences Forum
- Vol. 9 (1) , 19
The Development of the Women’s Wellness Program for Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is a chronic, relapsing, remitting functional disorder of the gut, characterised by abdominal pain, bloating, and changes in bowel habits, and associated with poor quality of life and depression. A common disorder in primary and specialty care, IBS affects 10–18% of New Zealanders and imposes significant personal, societal, and economic burdens. Although it is a condition of both mind and body, there is no holistic support program for people with IBS in Aotearoa. This project aimed: (1) To explore the impact of IBS with affected women and their health professionals. (2) Determine whether the Australian Women’s Wellness Program is adaptable, acceptable, and feasible for women in Aotearoa with IBS. (3) To codesign a prototype Women’s Wellness (IBS Aotearoa) program with affected women and their clinicians ready for feasibility testing. Eligible IBS participants (n = 15) comprising women 18 years or over, and legally able to consent, and separately health professionals or researchers (n = 15) working in the field of IBS participated in an in-depth individual or focus group interview. They were asked questions about their IBS journey, including diagnosis and treatment. Their feedback detailed how IBS adversely affected all aspects of quality of life, raised issues with diagnosis and treatment and articulated desired support approaches. When given information about the Women’s Wellness program and asked to provide feedback on it, all 30 interviewed participants agreed that a Women’s Wellness program health promotion approach for IBS was feasible, relevant, and warranted. A lifestyle program prototype based on the Women’s Wellness Program, tailored for those with IBS and led by an trained IBS health professional, is developed from these data ready for feasibility testing.
- 29 April 2022
- Published by MDPI AG in Medical Sciences Forum
- Vol. 9 (1) , 19
Open AccessThe Development of the Women’s Wellness Program for Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is a chronic, relapsing, remitting functional disorder of the gut, characterised by abdominal pain, bloating, and changes in bowel habits, and associated with poor quality of life and depression. A common disorder in primary and specialty care, IBS affects 10–18% of New Zealanders and imposes significant personal, societal, and economic burdens. Although it is a condition of both mind and body, there is no holistic support program for people with IBS in Aotearoa. This project aimed: (1) To explore the impact of IBS with affected women and their health professionals. (2) Determine whether the Australian Women’s Wellness Program is adaptable, acceptable, and feasible for women in Aotearoa with IBS. (3) To codesign a prototype Women’s Wellness (IBS Aotearoa) program with affected women and their clinicians ready for feasibility testing. Eligible IBS participants (n = 15) comprising women 18 years or over, and legally able to consent, and separately health professionals or researchers (n = 15) working in the field of IBS participated in an in-depth individual or focus group interview. They were asked questions about their IBS journey, including diagnosis and treatment. Their feedback detailed how IBS adversely affected all aspects of quality of life, raised issues with diagnosis and treatment and articulated desired support approaches. When given information about the Women’s Wellness program and asked to provide feedback on it, all 30 interviewed participants agreed that a Women’s Wellness program health promotion approach for IBS was feasible, relevant, and warranted. A lifestyle program prototype based on the Women’s Wellness Program, tailored for those with IBS and led by an trained IBS health professional, is developed from these data ready for feasibility testing.